About: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.91 (+0.84%)
CNTB NASDAQ Connect Biopharma Holdings Ltd
Carregando status da lista de acompanhamento…
Connect Biopharma Holdings Ltd share price
CNTB price activity
Último preço
$ 0,910
Variação (24h)
0,01 USD (0,84%)
Volume
1.84M
Volume (média 4 sem.)
-
Abertura
$ 0,89
Variação do dia
$ 0,85 - $ 0,98
Fechamento anterior
$ 0,90
Último negócio
06 Oct, 8:18 pm GMT+0
Atrasado
06 Oct, 8:18 pm GMT+0
CNTB price performance
-7,58%
5D
-50,79%
1M
-67,89%
YTD
-49,13%
1Y
Atrasado
06 Oct, 8:18 pm GMT+0
quote.marketSignals